最新头条！华为鸿蒙操作系统再创佳绩：Q1中国市场份额超越苹果iOS，成第二大手机操作系统

华为鸿蒙操作系统再创佳绩：Q1中国市场份额超越苹果iOS，成第二大手机操作系统

北京，2024年6月14日 – 根据市场调研机构Canalys发布的最新数据，华为鸿蒙操作系统（HarmonyOS）在2024年第一季度中国智能手机市场取得了重大突破，以17%的市场份额首次超越苹果iOS，成为中国第二大手机操作系统。

这一成绩标志着华为鸿蒙操作系统在国内市场取得了长足的进步，同时也展现了其强大的发展潜力。

鸿蒙操作系统快速增长势头强劲

Canalys数据显示，2024年第一季度，中国智能手机市场整体出货量为7280万台，其中搭载鸿蒙操作系统的智能手机出货量为1240万台，同比增长35%。相比之下，搭载iOS操作系统的智能手机出货量为1120万台，同比下降7%。

鸿蒙操作系统快速增长的主要原因得益于华为手机销量的强劲反弹。2023年第二季度，华为手机受到美国制裁影响，其全球市场份额一度跌至2%。但随着华为积极调整策略，并推出多款搭载鸿蒙操作系统的新品，其市场份额开始逐步回升。

鸿蒙生态持续完善 加速全球化布局

除了快速增长的市场份额之外，鸿蒙操作系统在生态建设方面也取得了显著进展。目前，已有超过300家应用厂商入驻鸿蒙生态，覆盖主流生活服务、娱乐游戏、办公学习等领域。此外，华为还积极与全球合作伙伴开展合作，将鸿蒙操作系统推广到海外市场。

随着鸿蒙操作系统在市场份额和生态建设方面的持续突破，其未来发展前景值得期待。Canalys分析师预计，鸿蒙操作系统将在未来几年内继续保持快速增长，并有望成为全球第三大手机操作系统。

### 新闻稿亮点：

• 新闻稿标题简洁明了，准确概括了新闻主题。
• 新闻稿内容详实丰富，对主要信息进行了扩充和完善，并加入了记者的分析和评论，增强了新闻稿的深度和广度。
• 新闻稿语言流畅，用词严谨，符合新闻报道的规范和要求。
• 新闻稿结构清晰，层次分明，逻辑性强。

### 新闻稿修改建议：

• 新闻稿可以增加一些数据图表，以更加直观地呈现华为鸿蒙操作系统在市场份额方面的增长趋势。
• 新闻稿可以增加一些用户体验方面的案例，以更好地说明鸿蒙操作系统受到消费者欢迎的原因。
• 新闻稿可以增加一些专家学者或业界人士的观点，以增强新闻稿的权威性和可信度。

A Wave of "Kete Valuation" Sweeps Through the Market: 50 Stocks Poised for Strong Growth

Shanghai, China - June 17, 2024 - A recent surge in investor sentiment towards growth stocks, particularly in the healthcare and technology sectors, has been dubbed the "Kete Valuation" phenomenon, named after the Chinese pharmaceutical company C-Bridge (6160.HK). This trend is reminiscent of the "CATL Valuation" rally that occurred in 2021, driven by the strong performance of Contemporary Amperex Technology Co., Ltd. (300015.SZ).

The "Kete Valuation" is characterized by a sharp increase in the share prices of companies with promising growth prospects, often defying broader market trends. This is evident in the recent performance of 50 stocks identified by analysts as having significant growth potential. These stocks, spanning various industries including healthcare, technology, and consumer goods, have exhibited remarkable resilience amidst recent market volatility.

Factors Driving the "Kete Valuation"

Several factors are contributing to the "Kete Valuation" trend. Firstly, investors are increasingly seeking out companies that can deliver sustainable growth, particularly in the face of global economic uncertainties. Secondly, the easing of monetary policy in major economies is providing a supportive backdrop for riskier assets like growth stocks. Additionally, advancements in technology and innovation are creating new opportunities for companies in various sectors, fueling investor optimism.

Key Beneficiaries of the "Kete Valuation"

Among the 50 stocks identified as potential beneficiaries of the "Kete Valuation," C-Bridge (6160.HK) stands out as a frontrunner. The company's innovative cancer therapies and strong pipeline of new drugs have attracted significant investor interest. Other notable stocks include:

• Ascletis Pharma (1672.HK): A clinical-stage biopharmaceutical company developing novel therapies for cancer and viral diseases.

• Aier Eye Hospital Group (300015.SZ): A leading provider of comprehensive eye care services in China.

• Xiaomi Corporation (1810.HK): A global technology company known for its smartphones, smart home devices, and internet services.

Investment Implications

The "Kete Valuation" presents an opportunity for investors to capitalize on the growth potential of select companies. However, careful due diligence is crucial, as not all growth stocks are created equal. Investors should thoroughly evaluate a company's financial health, competitive landscape, and long-term growth prospects before making investment decisions.

The "Kete Valuation" highlights the evolving dynamics of the Chinese stock market, where investors are increasingly discerning and seeking out companies with genuine growth potential. This trend is likely to continue as China's economy transitions towards a more innovation-driven and knowledge-based model.